Innate gastrointestinal immunity: Characterization of broadly active viral inhibitors

Antiviral Research

Volumn 49, Issue 3, 2001, Pages 157-167

  Singh, Indra P ^a   Coppenhaver, Dorian H ^a   Chopra, Ashok K ^a   Baron, Samuel ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Innate immunity; Intestinal defense; Intestinal virus inhibitors

Indexed keywords

ANTIVIRUS AGENT; GLYCOSIDASE; HIGH DENSITY LIPOPROTEIN; LIPID; NEURAMIDE; ORGANIC SOLVENT; PROTEINASE K; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; COMPARATIVE STUDY; DNA VIRUS; GASTROINTESTINAL TRACT; GLYCOLYSIS; IMMUNITY; MOLECULAR SIZE; PRIORITY JOURNAL; PROTEIN DEGRADATION; RNA VIRUS; VIROGENESIS; VIRUS ADSORPTION; VIRUS INFECTION; VIRUS TITRATION;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; FEMALE; GASTRIC MUCOSA; HERPESVIRUS 1, HUMAN; IMMUNITY, NATURAL; IMMUNOLOGIC FACTORS; MENGOVIRUS; MICE; MICE, INBRED ICR; MOLECULAR WEIGHT; SINDBIS VIRUS; SWINE; VACCINIA VIRUS; VERO CELLS; VESICULAR STOMATITIS-INDIANA VIRUS; VIRUS ACTIVATION;

DNA VIRUSES; SUIDAE;

EID: 0035050565     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(00)00140-6     Document Type: Article

References (27)

1. A new subtype of a natural viral inhibitor (CVI) that is stable in the gastrointestinal tract
2. Broadly active inhibitor of viruses spontaneously produced by many cell types in culture
3. Properties of poliovirus inhibitor from monkey brain
4. Recently described innate broad spectrum virus inhibitors
5. The interferons. Mechanisms of action and clinical applications
6. A defense role of a natural antiviral substance in the nervous system
7. Apparent dispensability of the carbohydrate moiety of human interferon for antiviral activity
8. Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract
9. Intrinsic factor secretion and cobalamin absorption. Physiological and pathophysiology in the gastrointestinal tract
10. Human coronavirus OC43 serum inhibitor and neutralizing antibody by a new plaque-reduction assay
11. Malabsorption of vitamin B12 in the pancreatic insufficiency of the adult and of the child
12. Receptor affinities as major determents of enterovirus tissue tropisms in humans
13. Non-specific viral inactivating substance (VIS) in human and mammalian sera
14. Studies on a heat-labile variola virus inhibitor in normal sera. I. Detection by the variola focus reduction assay and its general characteristics
15. Serum inhibitors of myxoviruses
16. A broadly active viral inhibitor in human and animal organ extracts and body fluids
17. Poliovirus inhibitor from the central nervous system of the rhesus monkey
18. Human serum lipoproteins as inhibitors of haemagglutination for selected togaviruses
19. Further characterization of a broad-spectrum antiviral substance in human serum
20. Vertebrate brains contain a broadly active antiviral substance
21. Lipoproteins account for part of the broad non-specific antiviral activity of human serum
22. Different sensitivity of hemagglutinating an hemolytic activities of Sendai virus to non-antibody inhibitors
23. Antiviral effects of apolipoprotein A-I and its synthetic amphipathic peptide analogs
24. Factors which influence inactivation of vesicular stomatitis virus by fresh human serum
25. Digestion of so-called resistant starch sources in the human small intestine
26. Inactivation of lysis of oncornaviruses by human serum